Epidemiology Practice Questions

Q: A child is suffering from varicella. The child's aunt is pregnant. At what earliest point can the child safely meet her aunt?

When the lesions have crusted. **Explanation:** **1. Why Option A is Correct:** The infectivity of Varicella (Chickenpox) is determined by the presence of live virus in the vesicular fluid and respiratory secretions. A patient is considered infectious from **48 hours before the onset of the rash** until **all lesions have crusted (scabbed over)**. Once the lesions are crusted, the virus is no longer viable, and the child is no longer contagious. For a pregnant woman, avoiding contact until this stage is crucial because primary varicella infection during pregnancy can lead to **Congenital Varicella Syndrome** (if early in pregnancy) or severe neonatal varicella. **2. Analysis of Incorrect Options:** * **Option B:** Incorrect. Meeting immediately while the child has active vesicles would expose the aunt to a high risk of infection via respiratory droplets or direct contact with lesion fluid. * **Option C:** Incorrect. Emotional attachment does not alter the biological period of communicability. This is a "distractor" option. * **Option D:** Incorrect. While waiting until after delivery is safe, it is not the *earliest* point. The question specifically asks for the earliest safe window, which is once the child is no longer infectious (crusting stage). **3. NEET-PG High-Yield Pearls:** * **Incubation Period:** 14–16 days (Range: 10–21 days). * **Secondary Attack Rate:** Very high (>90%). * **Rash Characteristics:** Centripetal distribution, pleomorphic (all stages of rash—papule, vesicle, crust—seen simultaneously), and "dew-drop on a rose petal" appearance. * **Post-Exposure Prophylaxis:** For susceptible pregnant women exposed to varicella, **Varicella-Zoster Immunoglobulin (VZIG)** should be administered within 72–96 hours to prevent or attenuate the disease. Live attenuated vaccines are contraindicated during pregnancy.

Q: Which of the following epidemiological characteristics are used to measure the ability of biological agents to induce clinically apparent illness?

Characteristic 1 and Characteristic 2. In epidemiology, the relationship between a host and an infectious agent is defined by specific metrics that measure the agent's behavior. To measure the ability of an agent to induce **clinically apparent illness**, we look at **Pathogenicity** and **Virulence**. ### **Explanation of the Correct Answer** * **Pathogenicity:** This is the ability of an infectious agent to produce disease in a host. It is measured as the ratio of the number of persons developing clinical illness to the total number of persons exposed to the infection. * **Virulence:** This refers to the degree of pathogenicity or the severity of the disease produced. It is often measured by the **Case Fatality Rate (CFR)**. * Both characteristics focus on the transition from subclinical infection to overt clinical disease (symptoms and severity). ### **Analysis of Incorrect Options** * **Infectivity (Characteristic 3):** This is the ability of an agent to enter, survive, and multiply in a host. It measures the proportion of exposed persons who become *infected* (regardless of whether they show symptoms). It is a measure of "transmission" rather than "illness." * **Options B, C, and D** are incorrect because they either exclude Pathogenicity/Virulence or incorrectly include Infectivity as a measure of clinical illness. ### **NEET-PG High-Yield Pearls** * **Infectivity:** Measured by the **Secondary Attack Rate (SAR)**. * **Pathogenicity:** Distinguishes "Infection" from "Disease." * **Virulence:** Distinguishes "Disease" from "Severe/Fatal Disease." * **Iceberg Phenomenon:** The "tip" represents clinical cases (Pathogenicity/Virulence), while the "submerged portion" represents subclinical cases and carriers (Infectivity). * **Serial Interval:** The gap between the onset of primary and secondary cases; useful for predicting the spread of an epidemic.

Q: The window period is defined as the time taken from:

Exposure to laboratory detection of the disease. ### Explanation **Correct Answer: B. Exposure to laboratory detection of the disease** The **Window Period** is the interval between the initial infection (exposure) and the time when the disease can be reliably detected by standard laboratory tests (such as antibodies or antigens). During this phase, the person is infected and potentially infectious, but diagnostic tests (like ELISA) may yield a **false negative** because the biomarkers have not yet reached detectable levels. This concept is most critically applied in HIV screening and blood transfusion safety. **Analysis of Incorrect Options:** * **Option A (Entry of pathogen to first clinical symptom):** This defines the **Incubation Period**. It is a clinical measure rather than a laboratory one. * **Option C (Entry into a cell to expulsion of first viral particle):** This defines the **Eclipse Phase**, a term used in virology to describe the time when the virus is replicating intracellularly and cannot be recovered from the host cell. * **Option D (Infection to maximum communicability):** This does not have a specific epidemiological name, though the period from infection to becoming infectious is known as the **Latent Period**. **NEET-PG High-Yield Pearls:** * **Generation Time:** The interval between the receipt of infection and maximal infectivity of the host (often coincides with the incubation period but is distinct). * **Serial Interval:** The time gap between the onset of the primary case and the onset of the secondary case. * **Iceberg Phenomenon:** The window period represents a portion of the "submerged" part of the iceberg (unseen cases). * **HIV Window Period:** With 4th generation ELISA (p24 antigen + antibody), the window period is reduced to approximately 14–21 days.

Q: Point prevalence studies tend to overestimate the occurrence of which of the following diseases?

Diseases with a long duration. **Explanation** The correct answer is **B. Diseases with a long duration.** **Understanding the Concept** Prevalence is defined by the formula: **Prevalence (P) ≈ Incidence (I) × Duration (D)**. Point prevalence acts like a "snapshot" in time. Because diseases with a long duration (chronic conditions) stay in the population pool for an extended period, they are much more likely to be captured during a single point-in-time survey. Conversely, diseases that resolve quickly (either through cure or death) are often missed by such snapshots, leading to an over-representation of chronic cases in prevalence data. This is known as **Neyman bias** (or length-time bias). **Analysis of Incorrect Options** * **A. Diseases with a high incidence:** Incidence refers to new cases. A disease can have high incidence but very short duration (e.g., Common Cold); in such cases, point prevalence remains low because patients recover quickly. * **C. Diseases with a high mortality:** High mortality reduces the duration of the disease. If a patient dies quickly after onset, they are less likely to be "present" in the population when a prevalence study is conducted. * **D. Diseases with a short duration:** These are underestimated by point prevalence studies because the "window of opportunity" to identify the case is very small. **NEET-PG High-Yield Pearls** * **Incidence** is the best indicator for the **etiology** of a disease and the efficacy of prevention programs. * **Prevalence** is the best indicator for **administrative planning** and estimating the burden of chronic diseases. * Prevalence **increases** with: Longer duration, prolongation of life without cure, and in-migration of cases. * Prevalence **decreases** with: High fatality rates, shorter duration, and improved cure rates.

Q: Which of the following terms best describes the ability of an infectious agent to cause disease?

Pathogenicity. ### Explanation The correct answer is **Pathogenicity**. In epidemiology, the interaction between an agent and a host is defined by specific metrics that describe the agent's behavior. **1. Why Pathogenicity is Correct:** Pathogenicity is defined as the **ability of an infectious agent to cause disease** (i.e., to produce clinical symptoms) in a susceptible host. It is calculated as the ratio of the number of persons developing clinical illness to the total number of persons exposed to the infection. It reflects the "all-or-none" phenomenon of whether a disease state is triggered following infection. **2. Analysis of Incorrect Options:** * **Infectivity (Option A):** This refers to the ability of an agent to enter, survive, and multiply in a host. It is a measure of how easily an agent can establish an infection, but it does not necessarily mean the host will show symptoms. * **Virulence (Option B):** This describes the **severity** of the disease produced. It is measured by the case fatality rate or the proportion of clinical cases that result in severe manifestations or death. If pathogenicity is "can it cause disease?", virulence is "how bad is the disease?". * **Communicability (Option D):** This is the ability of the agent to be transmitted from one host to another (directly or indirectly). **3. NEET-PG High-Yield Pearls:** * **Infectivity** is measured by the **Secondary Attack Rate (SAR)**. * **Virulence** is measured by the **Case Fatality Rate (CFR)**. * **Immunogenicity** is the ability of an infectious agent to induce specific immunity (antibody or cellular response) in the host. * **Iceberg Phenomenon:** Pathogenicity determines which cases appear "above the water line" (clinical cases), while infectivity includes those "below the water line" (subclinical/asymptomatic infections).

Q: Which of the following medical events occurred before 1900 AD?

Epidemiological work on cholera by John Snow. **Explanation:** The correct answer is **B. Epidemiological work on cholera by John Snow**. This question tests your knowledge of the historical milestones in Public Health and Epidemiology, a high-yield area for NEET-PG. **Why Option B is Correct:** John Snow, often regarded as the **"Father of Modern Epidemiology,"** conducted his landmark investigation into the Broad Street pump cholera outbreak in London in **1854**. By mapping cases and identifying the water source as the vehicle of transmission, he applied epidemiological methods long before the "Germ Theory" was fully established. **Analysis of Incorrect Options:** * **A. Establishment of the seat of social medicine at Oxford:** This occurred in **1943**. John Ryle was appointed as the first professor of Social Medicine there, marking a shift toward studying the social determinants of health. * **C. Work on scurvy by James Lind:** While this occurred before 1900 (**1747**), it is often considered a clinical trial rather than a broad "epidemiological work" in the context of infectious disease outbreaks. However, in many MCQ formats, if multiple events are pre-1900, John Snow is the prioritized answer for "Epidemiology" topics. *Note: If the question asks for the first clinical trial, James Lind is the answer.* * **D. Use of BCG vaccine:** The Bacillus Calmette-Guérin vaccine was first used in humans in **1921**. **High-Yield NEET-PG Pearls:** * **John Snow:** Associated with the "Ghost Map" and the removal of the Broad Street pump handle. * **James Lind:** Conducted the first controlled clinical trial (Scurvy/Citrus fruits). * **1850:** Lemuel Shattuck published the Shattuck Report, a cornerstone for public health in the US. * **1948:** Establishment of the WHO and the start of the Framingham Heart Study (pioneer of cohort studies).

Q: Which of the following is FALSE regarding longitudinal studies?

Incidence cannot be measured using these studies.. ### Explanation **1. Why Option C is the Correct (False) Statement:** In epidemiology, **longitudinal studies** (specifically prospective cohort studies) are the "gold standard" for calculating **Incidence**. These studies follow a group of disease-free individuals over a period of time to observe the development of new cases. Since Incidence is defined as the number of *new cases* occurring in a population at risk during a specific period, longitudinal studies are perfectly designed to measure it. Therefore, the statement "Incidence cannot be measured" is factually incorrect. **2. Analysis of Other Options:** * **Option A (True):** Longitudinal studies follow participants from exposure to outcome. By comparing the rate of disease in exposed vs. unexposed groups, researchers can establish a temporal relationship, which is essential for identifying **risk factors** and calculating Relative Risk (RR) and Attributable Risk (AR). * **Option B (True):** Because these studies observe the same individuals over an extended duration, they are ideal for documenting the **natural history of a disease**, including its onset, progression, and eventual outcome (recovery, disability, or death). **3. High-Yield Clinical Pearls for NEET-PG:** * **Directionality:** Longitudinal/Cohort studies move from **Cause to Effect** (Prospective). * **Key Metric:** They provide **Incidence**, **Relative Risk (RR)**, and **Attributable Risk (AR)**. * **Cross-sectional vs. Longitudinal:** Cross-sectional studies provide *Prevalence* (a snapshot), while Longitudinal studies provide *Incidence* (a sequence). * **Limitation:** They are time-consuming, expensive, and prone to "attrition bias" (loss to follow-up). * **Recall Bias:** Unlike case-control studies, longitudinal studies are less prone to recall bias because data on exposure is collected before the disease develops.

Question 1

A child is suffering from varicella. The child's aunt is pregnant. At what earliest point can the child safely meet her aunt?

Accepted Answer

When the lesions have crusted

Answer

Immediately

Answer

Anytime, as the child is the aunt's favorite

Answer

After the delivery of the baby

Question 2

Which of the following epidemiological characteristics are used to measure the ability of biological agents to induce clinically apparent illness?

Accepted Answer

Characteristic 1 and Characteristic 2

Answer

Characteristic 2 only

Answer

Characteristic 3 only

Answer

Characteristic 2 and Characteristic 3

Question 3

The window period is defined as the time taken from:

Accepted Answer

Exposure to laboratory detection of the disease

Answer

Entry of a pathogen to the appearance of the first clinical symptom

Answer

Entry into a cell to the expulsion of the first viral particle

Answer

Infection to the point of maximum communicability

Question 4

Sullivan's index measures which of the following?

Accepted Answer

Disability

Answer

Mortality

Answer

Morbidity

Answer

Infectivity

Question 5

According to the latest WHO classification and measurement of disability, what is the correct terminology?

Accepted Answer

ICD

Answer

IDEAS

Answer

ICIDH-II

Answer

WHO DAS I

Question 6

Point prevalence studies tend to overestimate the occurrence of which of the following diseases?

Accepted Answer

Diseases with a long duration

Answer

Diseases with a high incidence

Answer

Diseases with a high mortality

Answer

Diseases with a short duration

Question 7

Which of the following terms best describes the ability of an infectious agent to cause disease?

Accepted Answer

Pathogenicity

Answer

Infectivity

Answer

Virulence

Answer

Communicability

Question 8

Which of the following medical events occurred before 1900 AD?

Accepted Answer

Epidemiological work on cholera by John Snow

Answer

Establishment of the seat of social medicine at Oxford

Answer

Work on scurvy by James Lind

Answer

Use of BCG vaccine

Question 9

Which of the following is FALSE regarding longitudinal studies?

Accepted Answer

Incidence cannot be measured using these studies.

Answer

They can identify risk factors.

Answer

They are used to study the natural history of a disease.

Answer

All of the above.

Question 10

Which of the following represents the most logical sequence of the progression of a health condition?

Accepted Answer

Disease- Impairment- Disability- Handicap

Answer

Impairment- Disease- Disability- Handicap

Answer

Disease- Impairment- Handicap- Disability

Answer

Disease- Handicap- Impairment- Disability

Epidemiology — MCQs

Epidemiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?